Publication | Closed Access

Final overall survival data of sintilimab plus pemetrexed and platinum as First-Line treatment for locally advanced or metastatic nonsquamous NSCLC in the Phase 3 ORIENT-11 study

Orient-11 StudyMedicineMetastatic Nonsquamous NsclcMetronomic TherapyClinical TrialsPharmacotherapyCancer TreatmentOncologyRadiation OncologyPhase 3RadiologyHealth Sciences